Skip to content

ATT Compared With ATE in OSAS Children

Randomised Surgical Intervention Study Between Adenotonsillectomy and Adenotonsillotomy in Children With Obstructive Sleep Apnea Syndrome

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01676181
Acronym
RCT ATE/ATT
Enrollment
79
Registered
2012-08-30
Start date
2011-11-30
Completion date
2017-03-31
Last updated
2023-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive Sleep Apnea Syndrome in Children

Keywords

Obstructive sleep apnea syndrome, Children, Polysomnography, Surgery, Coblation, Tonsils, Tonsillectomy

Brief summary

Non-inferiority hypothesis; adenotonsillotomy is equally good as adenotonsillectomy in treating obstructive sleep apnea syndrome (OSAS) in children after one, three and ten years.

Detailed description

Background: Children with obstructive sleep apnea syndrome (OSAS) have apneas and disturbed sleep, which causes daytime symptoms such as neurobehavioral problems. OSAS is a significant cause of morbidity among children with an incidence of 1-3%, and a peak prevalence at 2-5 years of age. If left untreated it can cause severe complications including failure to thrive, cardiovascular complications, metabolic conditions and neurobehavioral disturbances (eg hyperactivity, inattention). Golden standard to diagnose OSA in children is full-night polysomnography (PSG) at a sleep laboratory including EEG, EOG, EMG, video-audiometry and respiratory recordings. At the Department of Otorhinolaryngology at Karolinska University Hospital, we have a sleep laboratory performing in-lab full-night polysomnography. The cause of OSAS in children is usually adenotonsillar hypertrophy, and the treatment of choice is surgical removal of tonsils and adenoid. Traditionally total adenotonsillectomy (ATE) has been performed, but in the last decade an alternative surgical method with partial adenotonsillotomy (ATT) is developed, where only the medial portion of the tonsil is removed. The newer method ATT is not fully evaluated in comparison with traditional ATE. There are studies comparing evaluating post-operative pain and bleeding showing a slight advantage for the TT-method. Very few studies are performed using objectively measured PSG-parameters to evaluate the effect of surgery on the sleep fragmentation and the sleep apneas. There is a need for such studies in the field of surgical treatment of pediatric OSA. This was also stated in a Cochrane database review from 2009, in which the conclusion was that there is a need for high quality randomised controlled trials to be carried out investigating the efficacy of surgical treatment of OSA in children. This makes this study important and of high clinical interest. Aims: To increase the knowledge of pediatric OSA and its treatment and to optimize the surgical treatment for children with OSA. To through a blinded randomized controlled trial compare the efficacy of ATT and ATE in treating OSA in children, including long-term follow-up after one, three and ten years. To evaluate postoperative pain after ATE and ATT. To evaluate quality of life after ATE and ATT.

Interventions

PROCEDUREAdenotonsillectomy

Total removal of tonsils and adenoid tissue with cold-steel

PROCEDUREAdenotonsillotomy

Partial removal of tonsils with coblation and total removal of adenoids with cold steel

Sponsors

Karolinska University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
2 Years to 6 Years
Healthy volunteers
No

Inclusion criteria

* Children aged 2-6 years * Clinical symptoms of OSAS (apneas, snoring, disturbed sleep) * Tonsil size 3-4 with the Brodsky scale (obstructing at least 50% of the oro-pharyngeal space) * Apnea-Hypopnea Index (AHI) 5-30 (moderate- severe OSA)

Exclusion criteria

* Clinical signs of craniofacial anomalies or neuromuscular disorders * Obesity * Earlier having had surgery of tonsils or adenoid * Bleeding disorder * Cardiopulmonary disorder

Design outcomes

Primary

MeasureTime frameDescription
Changes in polysomnographic parameter AHI (Apnea Hypopnea Index)One, three and ten yearsAHI; the number of apneas and hypopneas per sleep hour, is measured through polysomnography before and after surgery.

Secondary

MeasureTime frameDescription
Changes in quality of life questionnaires (OSA18 and SDQ)One, three and ten YearsParents answering to quality of life-questionnaire OSA18 and SDQ (Strengths and Difficulties Questionnaire) before and after surgical intervention

Other

MeasureTime frameDescription
Differences in postoperative painOne yearThe two groups will be compared with questionnaires and consumption of analgetics concerning the degree of postoperative pain.
Per- and postoperative bleedingOne yearThe two groups (ATT and ATE) will be compared concerning per- and postoperative bleeding.
Abnormalities in DNA analysis of blood and tonsil tissueone yearBlood and tissue samples will be frozen for future analysis of DNA. We have not yet decided which method we will use. There are other studies suggesting abnormalities in certain enzymes in children with tonsillar hypertrophy
Number of patients who need reoperationsOne, three and ten yearsThe patient may need reoperations, either because of postoperative bleeding or because the tonsils have regrowth
changes in polysomnographic parameters other than AHIone, three and ten yearsPolysomnograhic parameters, for example; the oxygen desaturation index (ODI), lowest oxygen saturation, the respiratory disturbance index (RDI), AHI in REM, total sleep time, time in REM, deep sleep, supine position etc.

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 20, 2026